Vir Biotechnology (VIR) Shares Issued (2018 - 2026)
Vir Biotechnology's (VIR) quarterly Shares Issued came in at $174000.0 in Q1 2026, down 87.99% quarter-over-quarter from $1.4 million in Q4 2025.
Vir Biotechnology (VIR) Shares Issued (2018 - 2026) Analysis & Trends
Vir Biotechnology has disclosed Shares Issued across 9 years of filings, most recently posting $174000.0 for Q1 2026.
- Shares Issued for Q1 2026 came in at $174000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (up 422.14% YoY), and the FY2025 annual result was $2.8 million, up 254.05% from the prior year.
- Shares Issued came in at $174000.0 for Q1 2026 at Vir Biotechnology, down from $1.4 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $2.4 million in Q2 2024 to a low of -$1.8 million in Q4 2024.
- The 5-year median for Shares Issued is $484000.0 (2022), against an average of $697800.0.
- Peak annual rise in Shares Issued reached 707.12% in 2024, while the deepest fall reached 2135.96% in 2024.
- Vir Biotechnology's Shares Issued stood at -$380000.0 in 2022, then soared by 123.42% to $89000.0 in 2023, then tumbled by 2135.96% to -$1.8 million in 2024, then jumped by 179.97% to $1.4 million in 2025, then slumped by 87.99% to $174000.0 in 2026.
- The last three Shares Issued figures came in at $174000.0 (Q1 2026), $1.4 million (Q4 2025), and $101000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 26,927.15 |
| 10 | Vir Biotechnology | 1.27 Bn | 1.27 Bn | - | 174,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174,000.00 |
| Mar 31, 2026 | 174,000.00 |
| Dec 31, 2025 | 1.45 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 101,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 221,000.00 |
| Mar 31, 2024 | 221,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | 790,000.00 |
| Sep 30, 2023 | 790,000.00 |
| Jun 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 295,000.00 |